• Clinical Trials Drive Innovation in Infant Gut Health

    Clinical Research News | In a food system that prioritizes profits and quantity over nutritional quality, most babies born today lack the gut microbes they need before kindergarten to train their immune system. Persephone Biome, a California-based biotech company, is tackling this issue with its latest product, the Daily Synergistic Synbiotic.

    Oct 2, 2025

  • Combining eCOA and Objective Digital Endpoints: Promise and Pitfalls

    Clinical Research News | The clinical research industry is awash in new data streams. With the rise of wearables, sensors, and smartphone-based assessments, objective digital measures are increasingly complementing traditional patient-reported outcomes. But should these endpoints be combined, or is it better to keep them separate? A recent SCOPE 365 ClinEco Connect session brought together experts and industry participants to wrestle with this question.

    Sep 30, 2025

  • nPhase Mixes Data, Evidence in One Platform, N-Power Medicine, VieCure Enter Partnership, More

    Clinical Research News | nPhase launches the first industry platform to harmonize real-world evidence and clinical trial data in one system; N-Power Medicine and VieCure have entered a strategic partnership; and more.

    Sep 25, 2025

  • Follow the Money: Adjustment Disorder Clinical Trial, Solving Trial Recruitment Failure, More

    Clinical Research News | Reunion Neuroscience will continue with its ongoing REKINDLE Phase 2 clinical trial in Adjustment Disorder (AjD) in cancer; Trially has launched Margo, an agentic AI solution that multiplies trial enrollment by converting patient matches into participants; and more.

    Sep 24, 2025

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025